Sort
21,281 grants matching “influenza”
B-cell Biology of Mucosal Immune Protection from SIV Challenge
$4,854,281Eric Hunter · Emory University · U19 · FY2015 · AI
Systems Immunogenetics of Biodefense Pathogens in the Collaborative Cross
$4,853,040Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2016 · AI
Adaptive and Innate Immunity, Memory and Repertoire in Vaccination and Infection
$4,833,207Mark M Davis · Stanford University · U19 · FY2016 · AI
VTEU: Phase I Influenza Vaccine Clinical Trial
$4,825,191Kathryn Margaret Edwards · Vanderbilt University · N01 · FY2016 · AI
Multiscale analysis of influenza host-pathogen interactions: Fluomics
$4,822,003Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2013 · AI
Conjugate nanoparticle platform development for HIV-1 envelope immunogens
$4,818,748Kevin O Saunders · Duke University · U19 · FY2023 · AI
Harnessing Human DC Subsets for Improved Muscosal Vaccines
$4,812,281Jacques F Banchereau · Baylor Research Institute · U19 · FY2010 · AI
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE
$4,798,692Adolpho Garcia-Sastre · · N01 · FY2007 · AI
ADDRESSING EMERGING INFECTIONS DISEASE IN BANGLADESH
$4,797,712Sayera Banu · International Ctr/Diarrhoeal Dis Res · U01 · FY2016 · GH
DIVINCI: Dissection of Influenza Vaccination and Infection for Childhood Immunity
$4,797,577Richard John Webby · St. Jude Children'S Research Hospital · U01 · FY2025 · AI
Conjugate nanoparticle platform development for HIV-1 envelope immunogens
$4,794,780Kevin O Saunders · Duke University · U19 · FY2024 · AI
GH16-006: Conducting Public Health Research in Kenya
$4,790,756Art Hapner · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2016 · GH
IP16-003, Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09
$4,770,431Cheryl Cohen · National Health Laboratory Service · U01 · FY2020 · IP
Harnessing Human DC Subsets for Improved Muscosal Vaccines
$4,764,161Yong-Jun Liu · Baylor Research Institute · U19 · FY2011 · AI
PREPARATION AND CHARACTERIZATION OF FIVE VACCINE CANDIDATES
$4,737,550Tracy Vachon · Charles River Laboratories Intntl, Inc. · N01 · FY2025 · AI
Conjugate nanoparticle platform development for HIV-1 envelope immunogens
$4,719,580Kevin O Saunders · Duke University · U19 · FY2022 · AI
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities
$4,713,497Scott Hensley · University Of Pennsylvania · N01 · FY2024 · AI
Adaptive and Innate Immunity, Memory and Repertoire in Vaccination and Infection
$4,710,430Mark M Davis · Stanford University · U19 · FY2018 · AI
TUNING OF PROGRAMMABLE PATHWAYS TO LIMIT EPIDEMICS OF INFLUENZA
$4,709,460University Of Massachusetts Medical School · · FY2019 · Department of the Navy
DEVELOPMENT OF THERAPEUTIC MEDICAL COUNTERMEASURES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES
$4,703,944Wilson Russell · Autoimmune Technologies, Llc · N01 · FY2015 · AI
Vaccine and Treatment Evaluation Units
$4,699,209Nadine Georges Rouphael · Emory University · UM1 · FY2022 · AI
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA AND SURVEILLANCE
$4,678,258John Jay Treanor · University Of Rochester · N01 · FY2009 · AI
Biodefense/Emerging Infection Vaccine Studies
$4,674,742Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Modeling Host Responses to Understand Severe Human Virus Infections
$4,673,565Yoshihiro Kawaoka · University Of Wisconsin-Madison · U19 · FY2015 · AI
Pandemic Influenza Translational Research and novel universal countermeasure development
$4,672,598Matthew Memoli · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI